Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| General Surgery | 23 | 2025 | 211 | 6.160 |
Why?
|
| Clinical Competence | 36 | 2023 | 726 | 5.410 |
Why?
|
| Laparoscopy | 26 | 2023 | 491 | 4.870 |
Why?
|
| Internship and Residency | 24 | 2025 | 810 | 4.110 |
Why?
|
| Education, Medical, Graduate | 14 | 2025 | 350 | 2.550 |
Why?
|
| User-Computer Interface | 12 | 2023 | 125 | 2.420 |
Why?
|
| Computer Simulation | 13 | 2023 | 484 | 2.250 |
Why?
|
| Educational Measurement | 11 | 2023 | 213 | 1.980 |
Why?
|
| Hernia, Ventral | 4 | 2023 | 27 | 1.590 |
Why?
|
| Computer-Assisted Instruction | 7 | 2015 | 79 | 1.460 |
Why?
|
| Suture Techniques | 6 | 2019 | 94 | 1.140 |
Why?
|
| Virtual Reality | 2 | 2023 | 16 | 0.960 |
Why?
|
| Patient Simulation | 3 | 2015 | 67 | 0.910 |
Why?
|
| Task Performance and Analysis | 8 | 2019 | 129 | 0.890 |
Why?
|
| Incisional Hernia | 2 | 2023 | 15 | 0.880 |
Why?
|
| Simulation Training | 3 | 2021 | 65 | 0.810 |
Why?
|
| Inventions | 1 | 2021 | 3 | 0.700 |
Why?
|
| Educational Technology | 1 | 2021 | 9 | 0.700 |
Why?
|
| Abdominal Cavity | 1 | 2021 | 7 | 0.680 |
Why?
|
| Education, Distance | 1 | 2021 | 34 | 0.680 |
Why?
|
| Abdominal Wall | 1 | 2021 | 24 | 0.660 |
Why?
|
| Surgeons | 1 | 2023 | 189 | 0.650 |
Why?
|
| Humans | 57 | 2025 | 64914 | 0.620 |
Why?
|
| Information Management | 1 | 2018 | 12 | 0.570 |
Why?
|
| Herniorrhaphy | 4 | 2023 | 71 | 0.520 |
Why?
|
| Curriculum | 9 | 2023 | 604 | 0.520 |
Why?
|
| Problem-Based Learning | 2 | 2014 | 36 | 0.510 |
Why?
|
| Models, Educational | 3 | 2014 | 67 | 0.500 |
Why?
|
| Liver | 9 | 2004 | 868 | 0.450 |
Why?
|
| Surgical Procedures, Operative | 2 | 2007 | 141 | 0.450 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2007 | 50 | 0.450 |
Why?
|
| Internet | 3 | 2020 | 466 | 0.450 |
Why?
|
| Laparoscopes | 2 | 2014 | 23 | 0.440 |
Why?
|
| Manikins | 2 | 2015 | 21 | 0.440 |
Why?
|
| Psychomotor Performance | 3 | 2013 | 136 | 0.420 |
Why?
|
| Adult | 25 | 2025 | 17279 | 0.420 |
Why?
|
| Pancreatic Polypeptide | 7 | 1998 | 10 | 0.410 |
Why?
|
| Competency-Based Education | 3 | 2023 | 30 | 0.410 |
Why?
|
| Pancreatitis | 6 | 2001 | 97 | 0.390 |
Why?
|
| Students, Medical | 3 | 2011 | 264 | 0.380 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2014 | 52 | 0.380 |
Why?
|
| Surgical Mesh | 3 | 2023 | 60 | 0.380 |
Why?
|
| Receptor, Insulin | 3 | 1999 | 52 | 0.380 |
Why?
|
| Faculty, Medical | 1 | 2014 | 201 | 0.380 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2007 | 90 | 0.360 |
Why?
|
| Time Factors | 8 | 2018 | 3755 | 0.340 |
Why?
|
| Accreditation | 3 | 2022 | 76 | 0.340 |
Why?
|
| Female | 26 | 2025 | 33873 | 0.330 |
Why?
|
| Burnout, Professional | 2 | 2023 | 142 | 0.320 |
Why?
|
| Artificial Intelligence | 2 | 2025 | 209 | 0.320 |
Why?
|
| Formative Feedback | 2 | 2019 | 8 | 0.310 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2008 | 161 | 0.310 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 2757 | 0.310 |
Why?
|
| Male | 30 | 2025 | 30904 | 0.280 |
Why?
|
| Specialties, Surgical | 1 | 2008 | 46 | 0.280 |
Why?
|
| Alcohol Drinking | 1 | 2011 | 322 | 0.280 |
Why?
|
| United States | 8 | 2021 | 8065 | 0.270 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2018 | 56 | 0.270 |
Why?
|
| Robotics | 1 | 2008 | 86 | 0.250 |
Why?
|
| Medical Errors | 2 | 2009 | 198 | 0.250 |
Why?
|
| Benchmarking | 2 | 2018 | 137 | 0.240 |
Why?
|
| Ergonomics | 4 | 2015 | 78 | 0.230 |
Why?
|
| Colitis, Ulcerative | 2 | 2005 | 76 | 0.230 |
Why?
|
| Physicians | 1 | 2011 | 484 | 0.230 |
Why?
|
| Intestine, Small | 1 | 2005 | 81 | 0.220 |
Why?
|
| Narration | 1 | 2025 | 53 | 0.220 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.220 |
Why?
|
| Retrospective Studies | 5 | 2023 | 6824 | 0.190 |
Why?
|
| Gallbladder Diseases | 1 | 2002 | 26 | 0.190 |
Why?
|
| Program Evaluation | 3 | 2014 | 488 | 0.180 |
Why?
|
| Interviews as Topic | 1 | 2024 | 529 | 0.180 |
Why?
|
| Automation | 1 | 2022 | 55 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 110 | 0.180 |
Why?
|
| Academic Medical Centers | 3 | 2016 | 304 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2003 | 108 | 0.180 |
Why?
|
| Educational Status | 1 | 2022 | 277 | 0.170 |
Why?
|
| Abdomen | 1 | 2021 | 94 | 0.170 |
Why?
|
| Insulin Resistance | 3 | 1995 | 414 | 0.160 |
Why?
|
| Observer Variation | 3 | 2007 | 215 | 0.160 |
Why?
|
| Professional Autonomy | 1 | 2020 | 19 | 0.160 |
Why?
|
| Hernia, Abdominal | 1 | 2020 | 9 | 0.160 |
Why?
|
| Mentoring | 1 | 2021 | 63 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2021 | 71 | 0.160 |
Why?
|
| Bayes Theorem | 1 | 2020 | 125 | 0.160 |
Why?
|
| Middle Aged | 10 | 2021 | 18170 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 19 | 0.150 |
Why?
|
| Self-Assessment | 1 | 2019 | 59 | 0.150 |
Why?
|
| Motor Skills | 2 | 2011 | 61 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 139 | 0.140 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 1998 | 1 | 0.140 |
Why?
|
| Electrocoagulation | 2 | 2011 | 13 | 0.140 |
Why?
|
| Spatial Navigation | 1 | 2018 | 7 | 0.140 |
Why?
|
| Massachusetts | 2 | 2025 | 2140 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 1999 | 224 | 0.140 |
Why?
|
| Pandemics | 1 | 2022 | 670 | 0.130 |
Why?
|
| Operative Time | 2 | 2016 | 91 | 0.130 |
Why?
|
| Liver Diseases | 1 | 1999 | 158 | 0.130 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 51 | 0.130 |
Why?
|
| Aptitude | 1 | 2017 | 10 | 0.130 |
Why?
|
| Visual Perception | 1 | 2017 | 45 | 0.130 |
Why?
|
| Fasting | 1 | 1996 | 52 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 439 | 0.120 |
Why?
|
| Learning | 1 | 2018 | 185 | 0.120 |
Why?
|
| Endoscopy | 1 | 2017 | 94 | 0.120 |
Why?
|
| Ireland | 2 | 2018 | 17 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1413 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 1690 | 0.120 |
Why?
|
| Food | 1 | 1996 | 76 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2013 | 603 | 0.120 |
Why?
|
| Colectomy | 3 | 2007 | 121 | 0.120 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 456 | 0.110 |
Why?
|
| Employee Performance Appraisal | 1 | 2015 | 9 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2007 | 142 | 0.110 |
Why?
|
| Education | 1 | 2015 | 67 | 0.110 |
Why?
|
| Operating Rooms | 2 | 2013 | 59 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 92 | 0.110 |
Why?
|
| Urologic Surgical Procedures | 1 | 2014 | 46 | 0.100 |
Why?
|
| Glucose | 4 | 1996 | 476 | 0.100 |
Why?
|
| Proteins | 1 | 1999 | 764 | 0.100 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 65 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1654 | 0.100 |
Why?
|
| Rats | 6 | 2001 | 1995 | 0.100 |
Why?
|
| New England | 2 | 2023 | 269 | 0.090 |
Why?
|
| Length of Stay | 3 | 2005 | 824 | 0.080 |
Why?
|
| Chronic Disease | 6 | 2001 | 741 | 0.080 |
Why?
|
| Equipment Design | 1 | 2011 | 359 | 0.080 |
Why?
|
| Signal Transduction | 1 | 1999 | 3154 | 0.070 |
Why?
|
| Gynecology | 1 | 2008 | 55 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 213 | 0.070 |
Why?
|
| Pancreatectomy | 1 | 1988 | 99 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2023 | 1314 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 41 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 622 | 0.060 |
Why?
|
| Aged | 4 | 2021 | 14884 | 0.060 |
Why?
|
| Endoscopy, Digestive System | 1 | 2007 | 32 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 1998 | 97 | 0.060 |
Why?
|
| Electromyography | 1 | 2006 | 98 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2016 | 3303 | 0.060 |
Why?
|
| Swine | 1 | 2007 | 394 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2005 | 55 | 0.060 |
Why?
|
| Insulin | 5 | 1996 | 696 | 0.060 |
Why?
|
| Ileal Neoplasms | 1 | 2005 | 3 | 0.060 |
Why?
|
| Peritoneum | 1 | 2005 | 31 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 31 | 0.060 |
Why?
|
| Ileostomy | 1 | 2005 | 28 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 92 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2011 | 2609 | 0.050 |
Why?
|
| Animals | 7 | 2007 | 21347 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5776 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2004 | 46 | 0.050 |
Why?
|
| Dissection | 1 | 2004 | 46 | 0.050 |
Why?
|
| Seroma | 1 | 2023 | 8 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2694 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2024 | 57 | 0.050 |
Why?
|
| Career Choice | 1 | 2025 | 132 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2006 | 270 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1160 | 0.050 |
Why?
|
| Burns | 1 | 2004 | 45 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 89 | 0.050 |
Why?
|
| Abscess | 1 | 2023 | 78 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 625 | 0.050 |
Why?
|
| Colonic Pouches | 1 | 2002 | 17 | 0.050 |
Why?
|
| Income | 1 | 2023 | 169 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 655 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2004 | 581 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 43 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2002 | 740 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 664 | 0.040 |
Why?
|
| Oleic Acid | 2 | 1998 | 20 | 0.040 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1999 | 3 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2001 | 222 | 0.040 |
Why?
|
| Adolescent | 4 | 2013 | 6283 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 185 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1999 | 203 | 0.040 |
Why?
|
| Glucagon | 4 | 1996 | 36 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1999 | 61 | 0.040 |
Why?
|
| Pharmaceutic Aids | 1 | 1998 | 2 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1998 | 24 | 0.030 |
Why?
|
| Microsomes | 1 | 1998 | 10 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 59 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 1998 | 31 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 1999 | 182 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1999 | 176 | 0.030 |
Why?
|
| Computers | 1 | 2017 | 49 | 0.030 |
Why?
|
| Liver Glycogen | 1 | 1996 | 2 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 153 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1999 | 309 | 0.030 |
Why?
|
| Gene Expression | 1 | 1999 | 856 | 0.030 |
Why?
|
| Feedback | 1 | 2015 | 91 | 0.030 |
Why?
|
| Perfusion | 3 | 1990 | 75 | 0.030 |
Why?
|
| Cattle | 1 | 1995 | 318 | 0.030 |
Why?
|
| Blood Glucose | 3 | 1996 | 498 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1999 | 1578 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 149 | 0.020 |
Why?
|
| Splanchnic Nerves | 2 | 1990 | 3 | 0.020 |
Why?
|
| Pancreas | 2 | 1990 | 154 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 2284 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1990 | 43 | 0.020 |
Why?
|
| Rotation | 1 | 2009 | 25 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 770 | 0.020 |
Why?
|
| Glycogen | 1 | 1989 | 40 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1990 | 286 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 1988 | 98 | 0.020 |
Why?
|
| Program Development | 1 | 2007 | 208 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2005 | 125 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2005 | 126 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2007 | 399 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 2003 | 11 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 454 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1988 | 554 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 989 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2001 | 3 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 246 | 0.010 |
Why?
|
| Phentolamine | 2 | 1990 | 7 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 610 | 0.010 |
Why?
|
| Propranolol | 2 | 1990 | 22 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1996 | 57 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5583 | 0.010 |
Why?
|
| Kinetics | 1 | 1996 | 759 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1990 | 4 | 0.010 |
Why?
|
| Oleic Acids | 1 | 1989 | 6 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1990 | 124 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1990 | 493 | 0.000 |
Why?
|
| Reference Values | 1 | 1989 | 326 | 0.000 |
Why?
|
| Cholinergic Fibers | 1 | 1989 | 4 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1989 | 139 | 0.000 |
Why?
|
| Hyperglycemia | 1 | 1989 | 104 | 0.000 |
Why?
|